NOTICE TO SHAREHOLDERS
For the Three and Nine Months Ended September 30, 2022
(Unaudited and Expressed in US Dollars)
POET TECHNOLOGIES INC.
Page 1 |
POET TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(Expressed in US Dollars)
Audited | ||||||||
September 30, | December 31, | |||||||
2022 | 2021 | |||||||
Assets | ||||||||
Current | ||||||||
Cash and cash equivalents (Note 2) | $ | 10,269,148 | $ | 14,941,775 | ||||
Short-term investments (Note 2) | - | 6,366,828 | ||||||
Prepaids and other current assets (Note 3) | 342,054 | 480,523 | ||||||
10,611,202 | 21,789,126 | |||||||
Investment in joint venture (Note 4) | 308,327 | 1,445,251 | ||||||
Property and equipment (Note 5) | 3,339,830 | 3,064,234 | ||||||
Patents and licenses (Note 6) | 532,236 | 528,476 | ||||||
Right of use assets (Note 7) | 274,689 | 326,890 | ||||||
$ | 15,066,284 | $ | 27,153,977 | |||||
Liabilities | ||||||||
Current | ||||||||
Accounts payable and accrued liabilities (Note 8) | $ | 1,422,380 | $ | 1,791,222 | ||||
Contract liabilities (Note 20) | 389,561 | - | ||||||
Lease liability (Note 7) | 193,269 | 101,074 | ||||||
Covid-19 government support loans (Note 9) | 28,916 | 31,660 | ||||||
2,034,126 | 1,923,956 | |||||||
Non-current lease liability (Note 7) | 117,568 | 258,274 | ||||||
2,151,694 | 2,182,230 | |||||||
Shareholders' Equity | ||||||||
Share capital (Note 10(b)) | 148,926,833 | 147,729,846 | ||||||
Warrants and compensation options (Note 11) | 5,248,908 | 5,328,455 | ||||||
Contributed surplus (Note 12) | 49,428,102 | 46,954,333 | ||||||
Accumulated other comprehensive loss | (2,945,544 | ) | (2,053,917 | ) | ||||
Deficit | (187,743,709 | ) | (172,986,970 | ) | ||||
12,914,590 | 24,971,747 | |||||||
$ | 15,066,284 | $ | 27,153,977 |
Commitments and contingencies (Note 14)
On behalf of the Board of Directors
/s/ Suresh Venkatesan | /s/ Chris Tsiofas | |
Director | Director |
The accompanying notes are an integral part of these condensed consolidated financial statements.
Page 2 |
POET TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND DEFICIT
(Expressed in US Dollars)
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Revenue (Note 20) | $ | 232,928 | $ | - | $ | 353,189 | $ | 209,100 | ||||||||
Operating expenses | ||||||||||||||||
Selling, marketing and administration (Note 19) | 2,074,704 | 2,362,922 | 6,904,621 | 6,973,634 | ||||||||||||
Research and development (Note 19) | 2,361,991 | 1,714,014 | 7,227,372 | 5,516,719 | ||||||||||||
Operating expenses | 4,436,695 | 4,076,936 | 14,131,993 | 12,490,353 | ||||||||||||
Operating loss before the following | (4,203,767 | ) | (4,076,936 | ) | (13,778,804 | ) | (12,281,253 | ) | ||||||||
Interest expense (Note 7) | (11,707 | ) | (19,729 | ) | (38,128 | ) | (349,107 | ) | ||||||||
Other income, including interest | 57,429 | 21,353 | 119,728 | 48,434 | ||||||||||||
Forgiveness of Covid-19 government support loans | - | 186,747 | - | 186,747 | ||||||||||||
Gain on the contribution of intellectual property to | ||||||||||||||||
joint venture (Note 4) | 496,115 | 1,057,500 | 496,115 | 1,057,500 | ||||||||||||
Share of loss in joint venture (Note 4) | (379,368 | ) | (634,666 | ) | (1,555,650 | ) | (634,666 | ) | ||||||||
Net loss | (4,041,298 | ) | (3,465,731 | ) | (14,756,739 | ) | (11,972,345 | ) | ||||||||
Deficit, beginning of period | (183,702,411 | ) | (165,824,491 | ) | (172,986,970 | ) | (157,317,877 | ) | ||||||||
Net loss | (4,041,298 | ) | (3,465,731 | ) | (14,756,739 | ) | (11,972,345 | ) | ||||||||
Deficit, end of period | $ | (187,743,709 | ) | $ | (169,290,222 | ) | $ | (187,743,709 | ) | $ | (169,290,222 | ) | ||||
Basic and diluted loss per share (Note 13) | $ | (0.11 | ) | $ | (0.10 | ) | $ | (0.40 | ) | $ | (0.35 | ) |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Expressed in US Dollars)
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Net loss | $ | (4,041,298 | ) | $ | (3,465,731 | ) | $ | (14,756,739 | ) | $ | (11,972,345 | ) | ||||
Other comprehensive loss - net of income taxes | ||||||||||||||||
Exchange differences on translating foreign operations | (671,162 | ) | (301,881 | ) | (891,627 | ) | (168,969 | ) | ||||||||
Comprehensive loss | $ | (4,712,460 | ) | $ | (3,767,612 | ) | $ | (15,648,366 | ) | $ | (12,141,314 | ) |
The accompanying notes are an integral part of these condensed consolidated financial statements.
Page 3 |
POET TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(Expressed in US Dollars)
For the Nine Months Ended September 30, | 2022 | 2021 | ||||||
Share Capital | ||||||||
Beginning balance | $ | 147,729,846 | $ | 114,586,260 | ||||
Funds from the exercise of warrants | 284,437 | 8,709,998 | ||||||
Fair value assigned to warrants exercised | 79,547 | 3,573,789 | ||||||
Conversion of convertible debentures | - | 3,571,342 | ||||||
Fair value of warrants issued upon the conversion of convertible debentures | - | (1,229,305 | ) | |||||
Funds from the exercise of stock options | 418,845 | 3,024,494 | ||||||
Fair value assigned to stock options exercised | 374,129 | 2,608,728 | ||||||
Funds from common shares issued on private placement | - | 11,815,595 | ||||||
Fair value of warrants issued on private placement | - | (3,766,007 | ) | |||||
Share issue costs | - | (1,143,034 | ) | |||||
Fair value of broker warrants issued as share issue costs | - | (288,197 | ) | |||||
Common shares issued to settle accounts payable | 40,029 | 13,814 | ||||||
September 30, | 148,926,833 | 141,477,477 | ||||||
Equity Component of Convertible Debentures | ||||||||
Beginning balance | - | 565,121 | ||||||
Fair value of equity component related to conversion of convertible debentures | - | (565,121 | ) | |||||
September 30, | - | - | ||||||
Warrants | ||||||||
Beginning balance | 5,328,455 | 5,557,002 | ||||||
Fair value of warrants issued upon the conversion of convertible debentures | - | 1,229,305 | ||||||
Fair value assigned to warrants and compensation warrants exercised | (79,547 | ) | (3,573,789 | ) | ||||
Fair value of broker warrants issued as share issue costs | - | 288,197 | ||||||
Fair value of warrants issued on private placement | - | 3,766,007 | ||||||
September 30, | 5,248,908 | 7,266,722 | ||||||
Contributed Surplus | ||||||||
Beginning balance | 46,954,333 | 44,407,679 | ||||||
Stock-based compensation | 2,847,898 | 3,352,995 | ||||||
Fair value of stock options exercised | (374,129 | ) | (2,608,728 | ) | ||||
Fair value effect of conversion of convertible debentures | - | 550,856 | ||||||
September 30, | 49,428,102 | 45,702,802 | ||||||
Accumulated Other Comprehensive Loss | ||||||||
Beginning balance | (2,053,917 | ) | (1,983,212 | ) | ||||
Other comprehensive (loss) income - translation adjustment | (891,627 | ) | (168,969 | ) | ||||
September 30, | (2,945,544 | ) | (2,152,181 | ) | ||||
Deficit | ||||||||
Beginning balance | (172,986,970 | ) | (157,317,877 | ) | ||||
Net loss | (14,756,739 | ) | (11,972,345 | ) | ||||
September 30, | (187,743,709 | ) | (169,290,222 | ) | ||||
Total shareholders' equity | $ | 12,914,590 | $ | 23,004,598 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
Page 4 |
POET TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Expressed in US Dollars)
For the Nine Months Ended September 30, | 2022 | 2021 | ||||||
CASH (USED IN) PROVIDED BY: | ||||||||
OPERATING ACTIVITIES | ||||||||
Net loss | $ | (14,756,739 | ) | $ | (11,972,345 | ) | ||
Adjustments for: | ||||||||
Depreciation of property and equipment (Note 5) | 770,080 | 612,522 | ||||||
Amortization of right of use asset (Note 7) | 123,345 | 142,985 | ||||||
Amortization of patents and licenses (Note 6) | 58,715 | 63,837 | ||||||
Other operating costs (Note 10) | - | 13,814 | ||||||
Accretion of debt discount on convertible debentures and non-cash interest (Note 7) | 38,128 | 195,545 | ||||||
Stock-based compensation (Note 12) | 2,847,898 | 3,352,995 | ||||||
Gain on contribution of intellectual property to joint venture (Note 4) | (496,115 | ) | (1,057,500 | ) | ||||
Share of loss in joint venture (Note 4) | 1,555,650 | 634,666 | ||||||
Forgiveness of covid-19 government support loans | - | (186,747 | ) | |||||
(9,859,038 | ) | (8,200,228 | ) | |||||
Net change in non-cash working capital accounts: | ||||||||
Prepaid and other current assets | 129,515 | 421,802 | ||||||
Accounts payable and accrued liabilities | (249,000 | ) | (247,444 | ) | ||||
Contract liabilities (Note 20) | 389,561 | - | ||||||
Cash flows from operating activities | (9,588,962 | ) | (8,025,870 | ) | ||||
INVESTING ACTIVITIES | ||||||||
Maturity (purchase) of short-term investments | 6,366,828 | (6,328,226 | ) | |||||
Purchase of property and equipment (Note 5) | (1,365,917 | ) | (693,342 | ) | ||||
Purchase of patents and licenses (Note 6) | (62,475 | ) | (17,470 | ) | ||||
Cash flows from investing activities | 4,938,436 | (7,039,038 | ) | |||||
FINANCING ACTIVITIES | ||||||||
Issue of common shares, net of share issue costs (Note 10) | 703,282 | 22,407,053 | ||||||
Payment of lease liability (Note 7) | (159,758 | ) | (178,209 | ) | ||||
Cash flows from financing activities | 543,524 | 22,228,844 | ||||||
EFFECT OF EXCHANGE RATE CHANGES ON CASH | (565,625 | ) | (32,316 | ) | ||||
NET CHANGE IN CASH AND CASH EQUIVALENTS | (4,672,627 | ) | 7,131,620 | |||||
CASH AND CASH EQUIVALENTS, beginning of period | 14,941,775 | 6,872,894 | ||||||
CASH AND CASH EQUIVALENTS, end of period | $ | 10,269,148 | $ | 14,004,514 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
Page 5 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
1. | DESCRIPTION OF BUSINESS |
POET Technologies Inc. is incorporated in the Province of Ontario. POET Technologies Inc. and its subsidiaries (the "Company") design and develop the POET Optical Interposer and Photonic Integrated Circuits for the data centre and tele-communications markets. The Company's head office is located at 120 Eglinton Avenue East, Suite 1107, Toronto, Ontario, Canada M4P 1E2. These condensed unaudited consolidated financial statements of the Company were approved by the Board of Directors of the Company on November 14, 2022.
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
These condensed unaudited consolidated financial statements of the Company and its subsidiaries were prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB").
These condensed unaudited consolidated financial statements do not include all of the information required for full annual financial statements and should be read in conjunction with the consolidated audited financial statements for the year ended December 31, 2021.
These condensed unaudited consolidated financial statements have been prepared on a going concern bases. As at September 30, 2022, the Company had accumulated losses of $(187,743,709) and working capital of $8,577,076. During the nine months ended September 30, 2022, the Company had negative cash flows from operations of $9,588,962. The Company has prepared a cash flow forecast which indicates that it does not have sufficient cash to meet its minimum expenditure commitments and therefore needs to raise additional funds to continue as a going concern. As a result, there is substantial doubt about the Company's ability to continue as a going concern for the next twelve months from the date of these condensed unaudited consolidated financial statements.
The Company has put in place a program of strict expense management while being focussed on generating sufficient revenue to fund operations over the next twelve months. The Company has a reasonable expectation that it will be able to manage its finances in order to continue its operations.
The preparation of financial statements in accordance with International Accounting Standards ("IAS") 34 Interim Financial Reporting, requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed below:
Basis of presentation
These consolidated financial statements include the accounts of POET Technologies Inc. and its subsidiaries; ODIS Inc. ("ODIS"), Opel Solar Inc. ("OPEL"), BB Photonics Inc.,("BB Photonics"), POET Technologies Pte Ltd. ("PTS") and POET Optoelectronics Shenzhen Co. Ltd. ("POET Shenzhen"). All intercompany balances and transactions have been eliminated on consolidation.
Foreign currency translation
These condensed unaudited consolidated financial statements are presented in U.S. dollars ("USD"), which is the Company's presentation currency.
Items included in the financial statements of each of the Company's subsidiaries are measured using the currency of the primary economic environment in which the entity operates (the "functional currency"). Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities not denominated in the functional currency of an entity are recognized in the statement of operations and deficit.
Page 6 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) |
Assets and liabilities of entities with functional currencies other than U.S. dollars are translated into the presentation currency at the year end rates of exchange, and the results of their operations are translated at average rates of exchange for the year. The resulting translation adjustments are included in accumulated other comprehensive loss in shareholders' equity. Additionally, foreign exchange gains and losses related to certain intercompany loans that are permanent in nature are included in accumulated other comprehensive loss. Elements of equity are translated at historical rates.
Financial Instruments
IFRS 9 introduced new classification and measurement models for financial assets. The investment classifications held-to-maturity and available-for-sale are no longer used and financial assets at fair value through other comprehensive income ("FVTOCI") were introduced. Financial assets held with an objective to hold assets in order to collect contractual cash flows which arise on specified dates that are solely principal and interest are measured at amortised cost using the effective interest method. Debt investments held with an objective to hold both assets in order to collect contractual cash flows which arise on specified dates that are solely principal and interest as well as selling the asset on the basis of fair value are measured at FVTOCI. All other financial assets are classified and measured at fair value through profit or loss ("FVTPL"). Financial liabilities are classified as either FVTPL or other financial liabilities, and the portion of the change in fair value that relates to the Company's credit risk is presented in other comprehensive loss. Instruments classified as FVTPL are measured at fair value with unrealized gains and losses recognized in net loss. Other financial liabilities are subsequently measured at amortised cost using the effective interest method.
Transaction costs that are directly attributable to the acquisition or issuance of financial assets and financial liabilities, other than financial assets and financial liabilities classified as FVTPL, are added to or deducted from the fair value on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities classified as FVTPL are recognized immediately in consolidated net loss.
Financial assets
The Company derecognizes a financial asset when the contractual rights to the cash flows from the financial asset expire, or it transfers the rights to receive the contractual cash flows in a transaction in which substantially all of the risks and rewards of ownership of the financial asset are transferred or in which the Company neither transfers nor retains substantially all of the risks and rewards of ownership and it does not retain control of the financial asset. Any interest in transferred financial assets that is created or retained by the Company is recognized as a separate asset or liability.
Financial liabilities
A financial liability is derecognized from the balance sheet when it is extinguished, that is, when the obligation specified in the contract is either discharged, cancelled or expires. Where there has been an exchange between an existing borrower and lender of debt instruments with substantially different terms, or there has been a substantial modification of the terms of an existing financial liability, this transaction is accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability. A gain or loss from extinguishment of the original financial liability is recognized in profit or loss.
The Company's financial instruments include cash and cash equivalents, short-term investments, accounts payable and accrued liabilities, contract liabilities and covid-19 government support loans.
Page 7 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) |
The following table outlines the classification of financial instruments under IFRS 9:
Financial Assets | ||
Cash and cash equivalents | Amortized cost | |
Short-term investments | Amortized cost | |
Financial Liabilities | ||
Accounts payable and accrued liabilities | Amortized cost | |
Contract liabilities | Amortized cost | |
Covid-19 government support loans | Amortized cost |
Convertible debentures are accounted for as a compound financial instrument with a debt component and a separate equity component. The debt component of these compound financial instruments is measured at fair value on initial recognition by discounting the stream of future interest and principal payments at the rate of interest prevailing at the date of issue for instruments of similar term and risk. The debt component is subsequently deducted from the total carrying value of the compound instrument to derive the equity component. The debt component is subsequently measured at amortized cost using the effective interest rate method. Interest expense based on the coupon rate of the debenture and the accretion of the liability component to the amount that will be payable on redemption are recognized through profit or loss as a finance cost.
Cash and cash equivalents
Cash and cash equivalents consist of cash in current accounts of $762,723 (2021 - $4,216,911) and funds invested in US and Canadian Term Deposits of $9,506,425 (2021 - $10,724,864) earning interest at rates ranging from 0.20% - 0.25% and maturing in less than 90 days.
Short-term investments
The short-term investments of nil (2021 - $6,366,828) consist of guaranteed investment certificates (GICs) held with one Canadian chartered bank.
Property and equipment
Property and equipment are recorded at cost. Depreciation is calculated based on the estimated useful life of the asset using the following method and useful lives:
Machinery and equipment | Straight Line, 5 years | |
Leasehold improvements | Straight Line, 5 years or life of the lease, whichever is less | |
Office equipment | Straight Line, 3 - 5 years |
Patents and licenses
Patents and licenses are recorded at cost and amortized on a straight line basis between 12 and 15 years. Ongoing maintenance costs are expensed as incurred.
Revenue recognition
Revenue is measured based on the consideration specified in a contract with a customer and excludes amounts collected on behalf of third parties. The Company recognizes revenue when it transfers control over a product or service to a customer.
Page 8 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) |
Service revenue
The Company provides contract services, primarily in the form of non-recurring revenue ("NRE") where control is passed to the customer over time. The contracts generally provide agreed upon milestones for customer payment which include but are not limited to the delivery of sample products, design reports and test reports. The customer makes payment when it has approved the delivery of the milestone. The Company must determine if the contract is made up of a series of independent performance obligations or a single performance obligation. Where NRE contracts contain multiple performance obligations for which a standalone transaction price can be assessed, revenue is recognized as each performance obligation is satisfied. Where NRE contracts contain a single performance obligation to be settled over time, revenue is recognized progressively based on the output method.
Other income
Interest income
Interest income on cash and cash equivalents and short-term investments is recognized as earned using the effective interest method.
Wage subsidies
Wages subsidies received from the Singaporean government are netted against payroll costs on the consolidated statements of operations and deficit.
Government Grants
Loans received exclusively from governmental agencies to support the Company throughout the COVID-19 pandemic qualify to be forgiven if certain conditions are met. Forgiveness of COVID-19 related loans will be recognized as other income on the consolidated statements of operations and deficit.
Stock-based compensation
Stock options and warrants awarded to non employees are measured using the fair value of the goods or services received unless that fair value cannot be estimated reliably, in which case measurement is based on the fair value of the stock options. Stock options and warrants awarded to employees are accounted for using the fair value method. The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.
Loss per share
Basic loss per share, net of taxes is calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period after giving effect to potentially dilutive financial instruments. The dilutive effect of stock options and warrants is determined using the treasury stock method.
Joint Venture
A joint arrangement is an arrangement among two or more parties where the parties are bound by a contractual arrangement and the contractual arrangement gives the parties joint control of the arrangement. A joint venture is a form of joint arrangement where an entity is independently formed and the parties jointly have rights to the net assets of the arrangement and therefore account for their interests under the equity method.
Page 9 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
3. | PREPAIDS AND OTHER CURRENT ASSETS |
The following table reflects the details of prepaids and other current assets:
September 30, | December 31, | |||||||
2022 | 2021 | |||||||
Sales tax recoverable and other current assets | $ | 66,955 | $ | 141,568 | ||||
Prepaid expenses | 186,599 | 50,668 | ||||||
Equipment deposit | 88,500 | 288,287 | ||||||
$ | 342,054 | $ | 480,523 |
4. | JOINT VENTURE |
The Company's contribution of intellectual property to Super Photonics Xiamen Co., Ltd ("SPX") was independently valued at $22,500,000 at the time of its contribution. During the nine months ended September 30, 2022, the Company recognized a gain of $496,115 (2021 - $2,587,500) related to its contribution of intellectual property to SPX in accordance with IAS 28. The Company only recognized a gain on the contribution of the intellectual property equivalent to the Sanan IC's interest in SPX, the unrecognized gain of $19,410,503 will be applied against the investment and periodically realized as the Company's ownership interest in SPX is reduced. At September 30, 2022, Sanan IC's and the Company's ownership interests were approximately 13.67% and 86.33% respectively.
SPX was determined to be a joint venture as both Sanan IC and POET exercise joint control over SPX. All relevant activity of SPX require unanimous consent.
The Company's investment in joint venture can be summarized as follows:
Balance, January 1, 2021 | $ | - | ||
Contribution of intellectual property | 22,500,000 | |||
Unrecognized gain on contribution of intellectual property | (19,912,500 | ) | ||
Share of loss in joint venture for the year ended December 31, 2021 | (1,142,249 | ) | ||
Investment balance, December 31, 2021 | 1,445,251 | |||
Recognized gain on contribution of intellectual property | 496,115 | |||
Share of loss in joint venture for the nine months ended September 30, 2022 | (1,555,650 | ) | ||
Effect of changes in foreign exchange rates | (77,389 | ) | ||
Investment balance, September 30, 2022 | $ | 308,327 |
Summarized financial information of the joint venture is as follows:
December 31, 2021 | September 30, 2022 | |||||||
Current assets | $ | 2,287,252 | $ | 794,524 | ||||
Intangible assets | $ | 22,500,000 | $ | 20,172,784 | ||||
Liabilities | $ | (44,683 | ) | $ | (424,144 | ) | ||
Owners Equity | $ | (24,742,569 | ) | $ | (20,543,164 | ) | ||
Net loss for the nine months ended September 30, 2021 and 2022 | $ | - | $ | 1,769,275 |
The Company recognizes its share of SPX's profits or losses using the equity method. On a weighted average basis, the Company recognized approximately 87.9% or $(1,555,650) of the net operating loss of SPX for the nine months ended September 30, 2022 (2021 - 95.3% or $(634,666)). The Company's current share of the operating loss is a result of the high value of the Company's initial contribution. The Company's share of the loss will reduce as Sanan IC periodically contributes cash and other assets to SPX.
Page 10 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
5. | PROPERTY AND EQUIPMENT |
Equipment not | Leasehold | Machinery and | Office | |||||||||||||||||
in service | improvements | equipment | equipment | Total | ||||||||||||||||
Cost | ||||||||||||||||||||
Balance, January 1, 2021 | $ | 227,147 | $ | 71,928 | $ | 3,994,657 | $ | 128,185 | $ | 4,421,917 | ||||||||||
Additions, net of returns (1) | (128,575 | ) | - | 842,877 | 57,221 | 771,523 | ||||||||||||||
Reclassification | (96,334 | ) | 47,393 | 48,941 | - | - | ||||||||||||||
Effect of changes in foreign exchange rates | (2,238 | ) | (2,206 | ) | (56,455 | ) | (2,137 | ) | (63,036 | ) | ||||||||||
Balance, December 31, 2021 | - | 117,115 | 4,830,020 | 183,269 | 5,130,404 | |||||||||||||||
Additions | 155,232 | - | 1,195,683 | 15,002 | 1,365,917 | |||||||||||||||
Reclassification | (141,976 | ) | - | 141,976 | - | - | ||||||||||||||
Effect of changes in foreign exchange rates | (553 | ) | (9,497 | ) | (323,760 | ) | (4,983 | ) | (338,793 | ) | ||||||||||
Balance, September 30, 2022 | 12,703 | 107,618 | 5,843,919 | 193,288 | 6,157,528 | |||||||||||||||
Accumulated Depreciation | ||||||||||||||||||||
Balance, January 1, 2021 | - | 10,777 | 1,146,014 | 79,372 | 1,236,163 | |||||||||||||||
Depreciation | - | 18,891 | 794,834 | 26,641 | 840,366 | |||||||||||||||
Effect on changes in foreign exchange rates | - | (142 | ) | (10,122 | ) | (95 | ) | (10,359 | ) | |||||||||||
Balance, December 31, 2021 | - | 29,526 | 1,930,726 | 105,918 | 2,066,170 | |||||||||||||||
Depreciation for the period | - | 18,091 | 730,831 | 21,158 | 770,080 | |||||||||||||||
Effect of changes in foreign exchange rates | - | (231 | ) | (17,712 | ) | (609 | ) | (18,552 | ) | |||||||||||
Balance, September 30, 2022 | - | 47,386 | 2,643,845 | 126,467 | 2,817,698 | |||||||||||||||
Carrying Amounts | ||||||||||||||||||||
At December 31, 2021 | $ | - | $ | 87,589 | $ | 2,899,294 | $ | 77,351 | $ | 3,064,234 | ||||||||||
At September 30, 2022 | $ | 12,703 | $ | 60,232 | $ | 3,200,074 | $ | 66,821 | $ | 3,339,830 |
(1) | During the year, the Company returned $196,490 in equipment to a vendor. The equipment was returned without penalty to the Company. |
6. | PATENTS AND LICENSES |
Cost | ||||
Balance, January 1, 2021 | $ | 837,102 | ||
Additions | 159,359 | |||
Balance, December 31, 2021 | 996,461 | |||
Additions | 62,475 | |||
Balance, September 30, 2022 | 1,058,936 | |||
Accumulated Depreciation | ||||
Balance, January 1, 2021 | 398,425 | |||
Amortization | 69,560 | |||
Balance, December 31, 2021 | 467,985 | |||
Amortization during the period | 58,715 | |||
Balance, September 30, 2022 | 526,700 | |||
Carrying Amounts | ||||
At December 31, 2021 | $ | 528,476 | ||
At September 30, 2022 | $ | 532,236 |
Page 11 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
7. | RIGHT OF USE ASSET AND LEASE LIABILITY |
The Company recognizes a lease liability and right of use asset relating to its commercial leases. The lease liability is measured at the present value of the remaining lease payments, discounted using the Company's incremental borrowing rate of 12%.
Right of use asset | Building | |||
Cost | ||||
Balance, January 1, 2021 | $ | 653,232 | ||
Effect of changes in foreign exchange rates | (4,122 | ) | ||
Balance, December 31, 2021 | 649,110 | |||
Lease modification(1) | 81,542 | |||
Effect of changes in foreign exchange rates | - | |||
Balance, September 30, 2022 | $ | 730,652 | ||
Accumulated Amortization | ||||
Balance, January 1, 2021 | 132,546 | |||
Amortization | 190,596 | |||
Effect of changes in foreign exchange rates | (922 | ) | ||
Balance, December 31, 2021 | 322,220 | |||
Amortization during the period | 123,345 | |||
Effect of changes in foreign exchange rates | 10,398 | |||
Balance, September 30, 2022 | 455,963 | |||
Carrying Amounts | ||||
At December 31, 2021 | $ | 326,890 | ||
At September 30, 2022 | $ | 274,689 | ||
Lease liability | ||||
Balance, January 1, 2021 | $ | 531,997 | ||
Interest expense | 67,675 | |||
Lease payments | (237,634 | ) | ||
Effect of changes in foreign exchange rates | (2,690 | ) | ||
Balance, December 31, 2021 | 359,348 | |||
Lease modification (1) | 81,542 | |||
Interest expense | 38,128 | |||
Lease payments | (159,758 | ) | ||
Effect of changes in foreign exchange rates | (8,423 | ) | ||
Balance, September 30, 2022 | $ | 310,837 |
(1) During the period ended September 30, 2022, the Company acquired additional space for its Allentown facility. The acquisition of the additional space resulted in a lease modification.
8. | ACCOUNTS PAYABLE AND ACCRUED LIABILITIES |
September 30, | December 31, | |||||||
2022 | 2021 | |||||||
Trade payable | $ | 995,591 | $ | 987,498 | ||||
Payroll related liabilities | 409,462 | 521,692 | ||||||
Accrued liabilities | 17,327 | 282,032 | ||||||
$ | 1,422,380 | $ | 1,791,222 |
Page 12 |
POET TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
9. | COVID-19 GOVERNMENT SUPPORT LOANS |
On April 9, 2020, the Canadian government launched the Canada Emergency Business Account ("CEBA") which is intended to support businesses during COVID-19 by providing interest free financing of up to $28,916 (CA$40,000) until December 31, 2023. If 75% of the loan is repaid by December 31, 2023, the loan recipient will be eligible for a loan forgiveness of the remaining 25% of the amount loaned. On April 15, 2020, the Company received a loan in the amount of $28,916 (2021 - $31,660) through the CEBA. If the loan has not been repaid by December 31, 2023, the outstanding amount will be automatically extended for an additional two years at 5% interest per annum payable monthly and maturing on December 31, 2025. The Company expects to repay 75% of the amount borrowed prior to December 31, 2023..
10. | SHARE CAPITAL |
(a) | AUTHORIZED | |
Unlimited number of common shares | ||
One special voting share | ||
(b) | COMMON SHARES ISSUED |
Number of Shares | Amount | |||||||
Balance, January 1, 2021 | 29,461,811 | $ | 114,586,260 | |||||
Issued on the conversion of convertible debentures | 1,119,750 | 3,571,342 | ||||||
Fair value of warrants issued on conversion of convertible debentures | - | (1,229,305 | ) | |||||
Share issue costs | - | (1,143,034 | ) | |||||
Shares issued to settle accounts payable | 1,678 | 13,814 | ||||||
Funds from common shares issued on private placement | 1,764,720 | 11,815,595 | ||||||
Fair value of warrants issued on private placement | - | (3,766,007 | ) | |||||
Fair value of broker warrants issued as share issue costs | - | (288,197 | ) | |||||
Funds from the exercise of stock options | 1,001,519 | 3,124,392 | ||||||
Fair value of stock options exercised | - | 2,699,042 | ||||||
Funds from the exercise of warrants and compensation warrants | 3,144,750 | 12,994,358 | ||||||
Fair value of warrants and compensation warrants exercised | - | 5,351,586 | ||||||
Balance, December 31, 2021 | 36,494,228 | 147,729,846 | ||||||
Funds from the exercise of stock options | 143,437 | 418,845 | ||||||
Fair value of stock options exercised | - | 374,129 | ||||||
Funds from the exercise of warrants | 72,500 | 284,437 | ||||||
Fair value of warrants exercised | - | 79,547 | ||||||
Shares issued to settle accounts payable | 5,422 | 40,029 | ||||||
Adjustment for 10 for 1 share consolidation | (272 | ) | - | |||||
Balance, September 30, 2022 | 36,715,315 | $ | 148,926,833 |
In 2020, the Company engaged with a firm to assist with its shareholder communications strategy. The terms of the agreement require the Company to issue common shares at certain pre-determined dates in satisfaction of past services rendered. During the nine months ended September 30, 2022, the Company settled $40,029 (2021 - $13,814) in accounts payable related to services rendered in 2021 under this agreement by issuing 5,422 (2021 - 1,678) common shares at a price of $7.38 (CAD$9.38) (2021 - $8.20 (CAD$10.10) per share to the firm.
Share Consolidation
On February 24, 2022, the Company filed Articles of Amendment to consolidate its common shares on a ten-for-one basis. For further clarity, for every ten (10) pre-consolidated common shares, shareholders received one (1) post-consolidated common share. On February 28, 2022, the Company's common shares began trading on the TSX Venture Exchange on a post consolidation basis. The Company's name and trading symbol remained unchanged. All references to share and per share amounts in these consolidated financial statements and accompanying notes to the consolidated financial statements have been retroactively restated to reflect the ten-for-one share consolidation.
Page 13 |
POET TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
11. | WARRANTS AND COMPENSATION OPTIONS |
The following table reflects the continuity of warrants and compensation options:
Number of | ||||||||||||
Historical | Warrants/ | |||||||||||
Average Exercise Price | Compensation options | Historical Fair value | ||||||||||
Balance, January 1, 2021 | $ | 3.90 | 3,269,050 | $ | 5,557,002 | |||||||
Fair value of warrant issued on private placement | 9.00 | 1,764,720 | 3,766,007 | |||||||||
Fair value of broker warrants issued on private placement | 6.70 | 105,883 | 288,197 | |||||||||
Fair value of warrants issued on conversion of | ||||||||||||
convertible debentures (Notes 9) | 3.80 | 1,119,750 | 1,229,305 | |||||||||
Historical fair value assigned to warrants exercised | 3.90 | (3,144,750 | ) | (5,351,586 | ) | |||||||
Fair value of expired warrants | 3.90 | (93,300 | ) | (160,470 | ) | |||||||
Balance, December 31, 2021 | 7.10 | 3,021,353 | 5,328,455 | |||||||||
Historical fair value assigned to warrants exercised | 3.90 | (72,500 | ) | (79,547 | ) | |||||||
Balance, September 30, 2022 | $ | 7.10 | 2,948,853 | $ | 5,248,908 |
12. | STOCK OPTIONS AND CONTRIBUTED SURPLUS |
Stock Options
On October 7, 2021, shareholders of the Company approved amendments to the Company's fixed 20% stock option plan (as amended, previously referred to as the "2020 plan", now referred to as the "2021 Plan"). Under the 2021 Plan, the board of directors may grant options to acquire common shares of the Company to qualified directors, officers, employees and consultants. The 2021 Plan provides that the number of common shares issuable pursuant to options granted under the 2021 Plan and pursuant to other previously granted options is limited to 7,090,518 (the "Number Reserved"). Any subsequent increase in the Number Reserved must be approved by shareholders of the Company and cannot, at the time of the increase, exceed 20% of the number of issued and outstanding shares. The stock options vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the 2021 Plan which grants discretion to the Board of Directors.
Stock option transactions and the number of stock options outstanding were as follows:
Historical | ||||||||
Number of | Weighted average | |||||||
Options | Exercise Price | |||||||
Balance, January 1, 2021 | 5,114,449 | $ | 3.30 | |||||
Expired/cancelled | (166,438 | ) | 3.40 | |||||
Exercised | (1,001,519 | ) | 3.00 | |||||
Granted | 1,013,125 | 8.50 | ||||||
Balance, December 31, 2021 | 4,959,617 | 4.40 | ||||||
Expired/cancelled | (117,438 | ) | 6.09 | |||||
Exercised | (143,437 | ) | 2.89 | |||||
Granted | 247,939 | 6.39 | ||||||
Balance, September 30, 2022 | 4,946,681 | $ | 4.50 |
Page 14 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
12. | STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued) |
During the nine months ended September 30, 2022, the Company granted 247,939 (nine months ended September 30, 2021 - 723,125) stock options to employees and consultants of the Company to purchase common shares at an average price of $6.39 (nine months ended September 30, 2021 - $8.80) per share.
During the nine months ended September 30, 2022, the Company recorded stock-based compensation of $2,847,898 (nine months ended September 30, 2021 - $3,352,995) relating to stock options that vested during the period.
The stock options granted were valued using the Black-Scholes option pricing model using the following assumptions:
Nine Months Ended September 30, | 2022 | 2021 | ||||||
Weighted average exercise price | $ | 6.39 | $ | 4.10 | ||||
Weighted average risk-free interest rate | 1.8% - 3.5 | % | 0.80% - 1.48 | % | ||||
Weighted average dividend yield | 0 | % | 0 | % | ||||
Weighted average volatility | 84.74 | % | 90.68 | % | ||||
Weighted average estimated life | 10 years | 10 years | ||||||
Weighted average share price | $ | 6.39 | $ | 8.80 | ||||
Share price on the various grant dates: | $4.37 - 6.86 | $6.40 - $9.40 | ||||||
Weighted average fair value | $ | 5.41 | $ | 7.60 |
The underlying expected volatility was determined by reference to the Company's historical share price movements, its dividend policy and dividend yield and past experience relating to the expected life of granted stock options.
The weighted average remaining contractual life and weighted average exercise price of options outstanding and of options exercisable as at September 30, 2022 are as follows:
Options Outstanding | Options Exercisable | ||||||||||||||||||||
Historical | Weighted | Historical | |||||||||||||||||||
Weighted | Average | Weighted | |||||||||||||||||||
Average | Remaining | Average | |||||||||||||||||||
Exercise | Number | Exercise | Contractual | Number | Exercise | ||||||||||||||||
Range | Outstanding | Price | Life (years) | Exercisable | Price | ||||||||||||||||
$ | 0.86 - $2.03 | 7,000 | $ | 2.03 | 5.84 | 7,000 | $ | 2.03 | |||||||||||||
$ | 2.04 - $2.88 | 1,520,929 | $ | 2.41 | 6.04 | 1,267,623 | $ | 2.38 | |||||||||||||
$ | 2.89 - $9.28 | 3,418,752 | $ | 5.20 | 7.24 | 2,152,811 | $ | 4.41 | |||||||||||||
4,946,681 | $ | 4.34 | 6.87 | 3,427,434 | $ | 3.66 |
Page 15 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
13. | LOSS PER SHARE |
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Numerator | ||||||||||||||||
Net loss | $ | (4,041,298 | ) | $ | (3,465,731 | ) | $ | (14,756,739 | ) | $ | (11,972,345 | ) | ||||
Denominator | ||||||||||||||||
Weighted average number of common shares outstanding - basic and diluted | 36,702,678 | 35,174,004 | 36,628,008 | 33,935,516 | ||||||||||||
Basic and diluted loss per share | $ | (0.11 | ) | $ | (0.10 | ) | $ | (0.40 | ) | $ | (0.35 | ) |
The effect of common share purchase options, warrants and broker warrants on the net loss is not reflected as they are anti-dilutive.
14. | COMMITMENTS AND CONTINGENCIES |
The Company has operating leases on four facilities; head office located in Toronto, Canada, design and testing operations located in Allentown, Pennsylvania (formerly in San Jose, California) and operating facilities located in Singapore and China. The Company's design and testing operations terminated a lease on January 31, 2021. A new lease was initiated on April 1, 2021 and expires on September 30, 2025. The lease on the Company's operating facilities in Singapore was initiated on November 1, 2019 with an original expiry of April 30, 2022. The lease on the Singapore faculty was renewed on May 1, 2022 and expires on May 31, 2023. The lease on the Company's operating facilities in China was initiated in November 19, 2021 and expires on November 18, 2023. As at September 30, 2022, the Company's head office was on a month to month lease term.
Remaining minimum annual rental payments to the lease expiration dates are as follows:
October 1, 2022 to December 31, 2022 | $ | 74,748 | ||
2023 and beyond | 368,333 | |||
$ | 443,081 |
15. | RELATED PARTY TRANSACTIONS |
Compensation to key management personnel were as follows:
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Salaries | $ | 504,099 | $ | 389,317 | $ | 1,472,296 | $ | 1,361,699 | ||||||||
Share-based payments (1) | 351,751 | 531,924 | 1,223,152 | 1,584,004 | ||||||||||||
Total | $ | 855,850 | $ | 921,241 | $ | 2,695,448 | $ | 2,945,703 |
(1) Share-based payments are the fair value of options granted to key management personnel and expensed during the various periods as calculated using the Black-Scholes model.
All transactions with related parties have occurred in the normal course of operations and are measured at the exchange amounts, which are the amounts of consideration established and agreed to by the related parties.
Page 16 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
16. | SEGMENT INFORMATION |
The Company and its subsidiaries operate in a single segment; the design, manufacture and sale of semi-conductor products and services for commercial applications. The Company's operating and reporting segment reflects the management reporting structure of the organization and the manner in which the chief operating decision maker regularly assesses information for decision making purposes, including the allocation of resources. A summary of the Company's operations is below:
OPEL, ODIS, POET Shenzhen and PTS
OPEL, ODIS, POET Shenzhen and PTS are the developers of the POET platform semiconductor process IP for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single die.
BB Photonics
BB Photonics developed photonic integrated components for the datacom and telecom markets utilizing embedded dielectric technology that enables the low-cost integration of active and passive devices into photonic integrated circuits. BB Photonics' operation is currently dormant.
On a consolidated basis, the Company operates geographically in China and Singapore (collectively "Asia"), the United States and Canada. Geographical information is as follows:
2022 | ||||||||||||||||
As of September 30, | Asia | US | Canada | Consolidated | ||||||||||||
Current assets | $ | 672,137 | $ | 198,559 | $ | 9,740,506 | $ | 10,611,202 | ||||||||
Investment in joint venture | 308,327 | - | - | 308,327 | ||||||||||||
Property and equipment | 2,726,557 | 613,273 | - | 3,339,830 | ||||||||||||
Patents and licenses | - | 532,236 | - | 532,236 | ||||||||||||
Right of use assets | 68,831 | 205,858 | - | 274,689 | ||||||||||||
Total Assets | $ | 3,775,852 | $ | 1,549,926 | $ | 9,740,506 | $ | 15,066,284 |
For the Nine Months Ended September 30, | Asia | US | Canada | Consolidated | ||||||||||||
Revenue | $ | 353,189 | $ | - | $ | - | $ | 353,189 | ||||||||
Selling, marketing and | ||||||||||||||||
administration | $ | (1,549,628 | ) | $ | (4,280,844 | ) | $ | (1,074,149 | ) | $ | (6,904,621 | ) | ||||
Research and development | (3,992,505 | ) | (3,099,397 | ) | (135,470 | ) | (7,227,372 | ) | ||||||||
Interest expense | (14,429 | ) | (23,699 | ) | - | (38,128 | ) | |||||||||
Share of loss in joint venture | (1,555,650 | ) | - | - | (1,555,650 | ) | ||||||||||
Gain from contribution of IP | ||||||||||||||||
to joint venture | 496,115 | - | - | 496,115 | ||||||||||||
Other income, including | ||||||||||||||||
Interest | - | - | 119,728 | 119,728 | ||||||||||||
Net loss | $ | (6,262,908 | ) | $ | (7,403,940 | ) | $ | (1,089,891 | ) | $ | (14,756,739 | ) |
2021 | ||||||||||||||||
As of December 31, | Asia | US | Canada | Consolidated | ||||||||||||
Current assets | $ | 537,647 | $ | 291,772 | $ | 20,959,707 | $ | 21,789,126 | ||||||||
Investment in joint venture | 1,445,251 | - | - | 1,445,251 | ||||||||||||
Property and equipment | 2,787,273 | 276,961 | - | 3,064,234 | ||||||||||||
Patents and licenses | - | 528,476 | - | 528,476 | ||||||||||||
Right of use assets | 150,134 | 176,756 | - | 326,890 | ||||||||||||
Total Assets | $ | 4,920,305 | $ | 1,273,965 | $ | 20,959,707 | $ | 27,153,977 |
Page 17 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
16. | SEGMENT INFORMATION (continued) |
For the Nine Months Ended September 30, | Asia | US | Canada | Consolidated | ||||||||||||
Revenue | $ | 209,100 | $ | - | $ | - | $ | 209,100 | ||||||||
Selling, marketing and | ||||||||||||||||
administration | (1,117,695 | ) | (4,235,900 | ) | (1,620,039 | ) | (6,973,634 | ) | ||||||||
Research and development | (3,158,470 | ) | (1,776,541 | ) | (581,708 | ) | (5,516,719 | ) | ||||||||
Interest | (12,172 | ) | (24,474 | ) | (312,461 | ) | (349,107 | ) | ||||||||
Share of loss in joint venture | (634,666 | ) | - | - | (634,666 | ) | ||||||||||
Gain from contribution of IP | ||||||||||||||||
to joint venture | 1,057,500 | - | - | - | ||||||||||||
Other income, including | ||||||||||||||||
interest and loan forgiveness | - | 186,747 | 48,434 | 235,181 | ||||||||||||
Net loss | $ | (3,656,403 | ) | $ | (5,850,168 | ) | $ | (2,465,774 | ) | $ | (11,972,345 | ) |
17. | FINANCIAL INSTRUMENTS AND RISK MANAGEMENT |
The Company's financial instruments consist of cash and cash equivalents, short-term investments, covid-19 government support loans, contract liabilities and accounts payable and accrued liabilities. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest risk arising from these financial instruments. The Company estimates that carrying value of these instruments approximates fair value due to their short term nature.
The Company has classified financial assets and (liabilities) as follows:
September 30, | December 31, | |||||||
2022 | 2021 | |||||||
Cash and cash equivalents, measured at amortized cost: | ||||||||
Cash and cash equivalents | $ | 10,269,148 | $ | 14,941,775 | ||||
Short-term investments | $ | - | $ | 6,366,828 | ||||
Other liabilities, measured at amortized cost: | ||||||||
Accounts payable and accrued liabilities | $ | (1,422,380 | ) | $ | (1,791,222 | ) | ||
Contract liabilities | $ | (389,561 | ) | $ | - | |||
Covid-19 government support loans | $ | (28,916 | ) | $ | (31,660 | ) |
Exchange Rate Risk
The functional currency of each of the entities included in the accompanying consolidated financial statements is the local currency where the entity is domiciled. Functional currencies include the Chinese Yuan, US, Singapore and Canadian dollar. Most transactions within the entities are conducted in functional currencies. As such, none of the entities included in the consolidated financial statements engage in hedging activities. The Company is exposed to a foreign currency risk when its subsidiaries hold current assets or current liabilities in currencies other than its functional currency. A 10% change in foreign currencies held would increase or decrease other comprehensive loss by $188,000.
Liquidity Risk
The Company currently does not maintain credit facilities. The Company's existing cash and cash resources are not considered sufficient to fund operating and investing activities beyond one year from the issuance of these unaudited condensed consolidated financial statements.
Page 18 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
18. | CAPITAL MANAGEMENT |
In the management of capital, the Company includes shareholders' equity (excluding accumulated other comprehensive loss and deficit) and cash and cash equivalents and short-term investments. The components of capital on September 30, 2022 were:
Cash and cash equivalents and short-term investments | $ | 10,269,148 | ||
Shareholders' equity | $ | 203,603,843 |
The Company's objective in managing capital is to ensure that financial flexibility is present to increase shareholder value through growth and responding to changes in economic and/or market conditions; to maintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future development of the business and to safeguard the Company's ability to obtain financing should the need arise.
In maintaining its capital, the Company has a strict investment policy which includes investing its surplus capital only in highly liquid, highly rated financial instruments. The Company reviews its capital management approach on an ongoing basis.
19. | EXPENSES |
Research and development costs can be analysed as follows:
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Wages and benefits | $ | 1,042,347 | $ | 531,984 | $ | 2,990,224 | $ | 1,801,609 | ||||||||
Subcontract fees | 400,475 | 246,571 | 1,720,487 | 1,440,719 | ||||||||||||
Stock-based compensation | 477,224 | 482,338 | 1,280,702 | 1,132,335 | ||||||||||||
Supplies | 441,945 | 453,121 | 1,235,959 | 1,142,056 | ||||||||||||
$ | 2,361,991 | $ | 1,714,014 | $ | 7,227,372 | $ | 5,516,719 |
Selling, marketing and administration costs can be analysed as follows:
Stock-based compensation | $ | 403,572 | $ | 813,526 | $ | 1,567,196 | $ | 2,220,660 | ||||||||
Wages and benefits | 646,349 | 623,731 | 1,983,180 | 2,033,023 | ||||||||||||
General expenses | 435,990 | 253,473 | 1,558,810 | 951,606 | ||||||||||||
Professional fees | 203,778 | 354,163 | 743,075 | 886,010 | ||||||||||||
Depreciation and amortization | 336,446 | 296,424 | 952,141 | 819,344 | ||||||||||||
Rent and facility costs | 48,569 | 21,605 | 100,219 | 62,991 | ||||||||||||
$ | 2,074,704 | $ | 2,362,922 | $ | 6,904,621 | $ | 6,973,634 |
Page 19 |
POET TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in US Dollars)
20. | REVENUE |
Disaggregated Revenues
The Company disaggregates revenue by timing of revenue recognition, that is, at a point in time and revenue over time. During the period, the Company recognized $353,189 (2021 - $209,100) from non-recurring engineering services. The revenue is recognized over time.
Revenue Contract Balances
Contract | ||||||||
Receivables | Liabilities | |||||||
Opening balance, January 1, 2022 | $ | - | $ | - | ||||
Revenues recognized | 353,189 | (757,746 | ) | |||||
Changes due to payment, fulfillment of performance obligations or other | (353,189) | 353,189 | ||||||
Effect of changes in foreign exchange rates | - | 14,996 | ||||||
Balance, September 30, 2022 | $ | - | $ | (389,561 | ) |
Page 20 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Poet Technologies Inc. published this content on 14 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 November 2022 23:09:52 UTC.